Tandem Diabetes Care, Inc.TNDMNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +43.62% | +22.30% | +8.46% | -31.39% | +2.74% |
| Gross Profit Growth | +68.77% | +25.07% | +11.58% | +7.73% | +6.35% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +83.83% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | -178.01% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | -176.32% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | -176.32% |
| Weighted Average Shares Growth | +0.87% | +1.65% | +3.16% | +3.23% | +3.15% |
| Weighted Average Shares Diluted Growth | +1.21% | +1.65% | +3.16% | +3.23% | +2.81% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | -69.14% | -8.67% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | -80.63% | -59.41% |
| Receivables Growth | +8.55% | +36.14% | +30.91% | +17.49% | +44.43% |
| Inventory Growth | -5.27% | -8.27% | -11.81% | -9.94% | -13.93% |
| Asset Growth | +1.57% | -2.01% | -6.59% | -8.67% | -8.94% |
| Book Value per Share Growth | -16.84% | -37.15% | -44.76% | -45.81% | -42.82% |
| Debt Growth | +13.93% | +3.28% | -5.89% | -5.60% | +19.17% |
| R&D Expense Growth | +22.52% | +171.24% | -2.45% | -6.31% | -11.75% |
| SG&A Expenses Growth | +23.42% | +26.35% | +16.29% | +6.86% | +6.86% |